Azathioprine
(WISNYKIQFMKSDQ-UHFFFAOYSA-N)
Structure
- SMILES
- Cn1cnc(c1Sc1ncnc2c1nc[n-]2)[N+](=O)[O-].[Na+]
- Molecular Formula:
- C9H6N7NaO2S
- Molecular Weight:
- 299.244
- Log P:
- 1.2981
- Hydrogen Bond Acceptor:
- 6
- Hydrogen Bond Donor:
- 0
- TPSA:
- 140.5
- CAS Number(s):
- 55774-33-9
Synonym(s)
1.
Azathioprine
2.
Azathioprine Sodium
3.
Azathioprine Sodium Salt
4.
Azathioprine Sulfate
5.
Azothioprine
6.
Immuran
7.
Imuran
8.
Imurel
9.
Sodium, Azathioprine
External Link(s)
| MeSH | D001379 |
| PubChem Compound | 11529527 |
| CHEMBL | CHEMBL1200400 |
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Asthenia | FAERS: 3 | US FAERS | |
| 2 | Fatigue | FAERS: 3 | US FAERS | |
| 3 | Pancytopenia | FAERS: 3 | US FAERS | |
| 4 | Septic Shock | FAERS: 3 | US FAERS | |
| 5 | Ascites | FAERS: 2 | US FAERS | |
| 6 | Aspartate Aminotransferase Increased | FAERS: 2 | US FAERS | |
| 7 | Pneumonia | FAERS: 2 | US FAERS | |
| 8 | Pulmonary Eosinophilia | FAERS: 2 | US FAERS | |
| 9 | Abdominal Pain | FAERS: 1 | US FAERS | |
| 10 | Actinic keratosis | FAERS: 1 | US FAERS | |
| 11 | Acute respiratory failure | FAERS: 1 | US FAERS | |
| 12 | Alanine Aminotransferase Increased | FAERS: 1 | US FAERS | |
| 13 | Alopecia | FAERS: 1 | US FAERS | |
| 14 | Autoimmune hepatitis | FAERS: 1 | US FAERS | |
| 15 | Basal cell carcinoma | FAERS: 1 | US FAERS | |
| 16 | Blood alkaline phosphatase increased | FAERS: 1 | US FAERS | |
| 17 | Cellulitis | FAERS: 1 | US FAERS | |
| 18 | Cerebral Infarction | FAERS: 1 | US FAERS | |
| 19 | Clostridium difficile toxin test positive | FAERS: 1 | US FAERS | |
| 20 | Drug ineffective | FAERS: 1 | US FAERS | |
| 21 | Dysarthria | FAERS: 1 | US FAERS | |
| 22 | Dysplasia | FAERS: 1 | US FAERS | |
| 23 | Headache | FAERS: 1 | US FAERS | |
| 24 | Hemiplegia | FAERS: 1 | US FAERS | |
| 25 | Hepatic necrosis | FAERS: 1 | US FAERS | |
| 26 | Hepatitis | FAERS: 1 | US FAERS | |
| 27 | Hepatomegaly | FAERS: 1 | US FAERS | |
| 28 | Hepatosplenic T-cell lymphoma | FAERS: 1 | US FAERS | |
| 29 | Human herpesvirus 8 infection | FAERS: 1 | US FAERS | |
| 30 | Hydrocephalus | FAERS: 1 | US FAERS | |
| 31 | Hyperkeratosis | FAERS: 1 | US FAERS | |
| 32 | Hyperreflexia | FAERS: 1 | US FAERS | |
| 33 | Lethargy | FAERS: 1 | US FAERS | |
| 34 | Metastasis | FAERS: 1 | US FAERS | |
| 35 | Musculoskeletal stiffness | FAERS: 1 | US FAERS | |
| 36 | Mutism | FAERS: 1 | US FAERS | |
| 37 | Myalgia | FAERS: 1 | US FAERS | |
| 38 | Nausea | FAERS: 1 | US FAERS | |
| 39 | Neutropenia | FAERS: 1 | US FAERS | |
| 40 | Nodule | FAERS: 1 | US FAERS | |
| 41 | Oliguria | FAERS: 1 | US FAERS | |
| 42 | Osteomyelitis | FAERS: 1 | US FAERS | |
| 43 | Petechiae | FAERS: 1 | US FAERS | |
| 44 | Photophobia | FAERS: 1 | US FAERS | |
| 45 | Pneumocystis jiroveci pneumonia | FAERS: 1 | US FAERS | |
| 46 | Pneumonitis | FAERS: 1 | US FAERS | |
| 47 | Psoriasis | FAERS: 1 | US FAERS | |
| 48 | Pulmonary toxicity | FAERS: 1 | US FAERS | |
| 49 | Sepsis | FAERS: 1 | US FAERS | |
| 50 | Somnolence | FAERS: 1 | US FAERS | |
| 51 | Splenomegaly | FAERS: 1 | US FAERS | |
| 52 | Squamous cell carcinoma of skin | FAERS: 1 | US FAERS | |
| 53 | Squamous cell carcinoma | FAERS: 1 | US FAERS | |
| 54 | Thrombocytopenia | FAERS: 1 | US FAERS | |
| 55 | Toxicity to various agents | FAERS: 1 | US FAERS | |
| 56 | Urinary Incontinence | FAERS: 1 | US FAERS | |
| 57 | Vomiting | FAERS: 1 | US FAERS | |
| 58 | Weight decreased | FAERS: 1 | US FAERS | |
| 59 | jaundice | FAERS: 1 | US FAERS | |
| 60 | nervous system disorder | FAERS: 1 | US FAERS |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.